Ceria is Developing Novel RNA Drug Products Targeting Acute, Severe Inflammation

Inflammation Plays a Key Role in Multiple Diseases

CRITICAL CARE

Select conditions we are targeting:
Acute Respiratory Inflammation [ALI, ARF, ARDS], Acute
Kidney Injury [AKI], Toxemic Sepsis, Acute Pancreatitis

First-in-class drug products to block the root cause of inflammation from acute critical conditions.
Find out how

CRITICAL CARE

Select conditions we are targeting:
Acute Respiratory Inflammation [ALI, ARF, ARDS], Acute Kidney Injury [AKI], Toxemic Sepsis, Acute Pancreatitis

First-in-class drug products to block the root cause of inflammation from acute critical conditions.
Find out how

Advanced Wound Care

Select conditions we are targeting:
Early-stage DFU, Advanced DFU, Pressure Ulcers

First-in-class drug products to treat non-healing wounds by blocking the inflammatory cascade.
Find out how

Advanced Wound Care

Select conditions we are targeting:
Early-stage DFU, Advanced DFU, Pressure Ulcers

First-in-class drug products to treat non-healing wounds by blocking the inflammatory cascade.
Find out how

GI

Select conditions we are targeting:
Ulcerative Colitis, Crohn’s Disease

First-in-class drug products to treat inflammatory bowel disease [IBD] by blocking the inflammatory pathway.
Find out how

GI

Select conditions we are targeting:
Ulcerative Colitis, Crohn’s Disease

First-in-class drug products to treat inflammatory bowel disease [IBD] by blocking the inflammatory pathway.
Find out how
Restoring Natural Healing.

Recovering from injury and infection through the body’s inflammatory process is the norm, but sometimes inflammation can become uncontrolled. Unregulated inflammation is proven causal to several acute and chronic conditions and diseases. By boosting the body’s innate ability to regulate inflammation–the consequences of inflammation are eliminated, and tissues can heal normally.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation and resolving disease itself.

Our Science
Restoring Natural Healing.

Recovering from injury and infection through the body’s inflammatory process is the norm, but sometimes inflammation can become uncontrolled. Unregulated inflammation is proven causal to several acute and chronic conditions and diseases. By boosting the body’s innate ability to regulate inflammation–the consequences of inflammation are eliminated, and tissues can heal normally.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation and resolving disease itself.

Our Science

LATEST NEWS

Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to Advance Development of a Novel Treatment for Non-healing Diabetic Foot Ulcers

Go to article

Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD Contract to Advance Development of a Novel Treatment for Acute Lung Injuries

Go to article

Photopolymerized Zwitterionic Hydrogels with a Sustained Delivery of Cerium Oxide Nanoparticle-miR146a Conjugate Accelerate Diabetic Wound Healing

Go to article
LATEST NEWS

Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to Advance Development of a Novel Treatment for Non-healing Diabetic Foot Ulcers

Go to article

Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD Contract to Advance Development of a Novel Treatment for Acute Lung Injuries

Go to article

Photopolymerized Zwitterionic Hydrogels with a Sustained Delivery of Cerium Oxide Nanoparticle-miR146a Conjugate Accelerate Diabetic Wound Healing

Go to article

CONTACT US